Mihaela Ghita-Pettigrew

Dr. Mihaela Ghita-Pettigrew

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MGMihaela Ghita-Pettigrew
Mihaela Ghita-Pettigrew
SMStephen J. Mcmahon
Stephen J. Mcmahon
LTLaura E. Taggart
Laura E. Taggart
Karl ButterworthKarl Butterworth
Karl Butterworth
GSGiuseppe Schettino
Giuseppe Schettino
KPKevin Prise
Kevin Prise
Gold nanoparticles (GNPs) have been demonstrated as effective radiosensitizing agents in a range of preclinical models using broad field sources of various energies. This study aimed to distinguish between these mechanisms by applying subcellular targeting using a soft X-ray microbeam in combination with GNPs. DNA damage and repair kinetics were determined following nuclear and cytoplasmic irradiation using a soft X-ray (carbon K-shell, 278 eV) microbeam in MDA-MB-231 breast cancer and AG01522 fibroblast cells with and without GNPs. To investigate the mechanism of the GNP induced radiosensitization, GNP-induced mitochondrial depolarisation was quantified by TMRE staining, and levels of DNA damage were compared in cells with depolarised and functional mitochondria. Differential effects were observed following radiation exposure between the two cell lines. These findings were validated 24 hours after removal of GNPs by flow cytometry analysis of mitochondrial depolarisation. This study provides further evidence that GNP radiosensitisation is mediated by mitochondrial function and it is the first report applying a soft X-ray microbeam to study the radiobiological effects of GNPs to enable the separation of physical and biological effects.

28 December 2017 in Radiation Oncology
Verified
Journal Article
Open access
PDF file
MGMihaela Ghita-Pettigrew
Mihaela Ghita-Pettigrew
SMStephen J. Mcmahon
Stephen J. Mcmahon
HTHannah F. Thompson
Hannah F. Thompson
CMConor K. McGarry
Conor K. McGarry
RKRaymond King
Raymond King
KPKevin Prise
Kevin Prise
Preclinical radiation biology has become increasingly sophisticated due to the implementation of advanced small animal image guided radiation platforms into laboratory investigation. These small animal radiotherapy devices enable state-of-the-art image guided therapy (IGRT) research to be performed by combining high-resolution cone beam computed tomography (CBCT) imaging with an isocentric irradiation system. Such platforms are capable of replicating modern clinical systems similar to those that integrate a linear accelerator with on-board CBCT image guidance. In this study, we present a dosimetric evaluation of the small animal radiotherapy research platform (SARRP, Xstrahl Inc.) focusing on small field dosimetry. Physical dosimetry was assessed using ion chamber for calibration and radiochromic film, investigating the impact of beam focus size on the dose rate output as well as beam characteristics (beam shape and penumbra). Two film analysis tools) have been used to assess the dose output using the 0.5 mm diameter aperture. Good agreement (between 1.7–3%) was found between the measured physical doses and the data provided by Xstrahl for all apertures used. Furthermore, all small field dosimetry data are in good agreement for both film reading methods and with our Monte Carlo simulations for both focal spot sizes. Furthermore, the small focal spot has been shown to produce a more homogenous beam with more stable penumbra over time. FilmQA Pro is a suitable tool for small field dosimetry, with a sufficiently small sampling area (0.1 mm) to ensure an accurate measurement. The electron beam focus should be chosen with care as this can potentially impact on beam stability and reproducibility.

2 January 2018 in International Journal of Radiation Biology
Verified
Journal Article
Closed access
MGMihaela Ghita-Pettigrew
Mihaela Ghita-Pettigrew
Cristian Fernandez-PalomoCristian Fernandez-Palomo
Cristian Fernandez-Palomo
HFHisanori Fukunaga
Hisanori Fukunaga
PFPil M. Fredericia
Pil M. Fredericia
GSGiuseppe Schettino
Giuseppe Schettino
KPKevin Prise
Kevin Prise
Purpose: This review follows the development of microbeam technology from the early days of single cell irradiations, to investigations of specific cellular mechanisms and to the development of new treatment modalities in vivo. A number of microbeam applications are discussed with a focus on pre-clinical modalities and translation towards clinical application. Conclusions: The development of radiation microbeams has been a valuable tool for the exploration of fundamental radiobiological response mechanisms. The strength of micro-irradiation techniques lies in their ability to deliver precise doses of radiation to selected individual cells in vitro or even to target subcellular organelles. These abilities have led to the development of a range of microbeam facilities around the world allowing the delivery of precisely defined beams of charged particles, X-rays, or electrons. In addition, microbeams have acted as mechanistic probes to dissect the underlying molecular events of the DNA damage response following highly localized dose deposition. Further advances in very precise beam delivery have also enabled the transition towards new and exciting therapeutic modalities developed at synchrotrons to deliver radiotherapy using plane parallel microbeams, in Microbeam Radiotherapy (MRT).

6 April 2022 in Clinical and Translational Radiation Oncology
Verified
Journal Article
Open access
KBKathryn Brown
Kathryn Brown
MGMihaela Ghita-Pettigrew
Mihaela Ghita-Pettigrew
Ludwig DuboisLudwig Dubois
Ludwig Dubois
Dirk De RuysscherDirk De Ruysscher
Dirk De Ruysscher
KPKevin Prise
Kevin Prise
Karl ButterworthKarl Butterworth
Karl Butterworth
To provide a scoping review of published studies using small animal irradiators and highlight the progress in preclinical radiotherapy (RT) studies enabled by these platforms since their development and commercialization in 2007. PubMed searches and manufacturer records were used to identify 907 studies that were screened with 359 small animal RT studies included in the analyses. These articles were classified as biology or physics contributions and into subgroups based on research aims, experimental models and other parameters to identify trends in the preclinical RT research landscape. From 2007 to 2021, most published articles were biology contributions (62%) whilst physics contributions accounted for 38% of the publications. The main research areas of physics articles were in dosimetry and calibration (24%), treatment planning and simulation (22%), and imaging (22%) and the studies predominantly used phantoms (41%) or in vivo models (34%). The majority of biology contributions were tumor studies (69%) with brain being the most commonly investigated site. The most frequently investigated areas of tumor biology were evaluating radiosensitizers (33%), model development (30%) and imaging (21%) with cell-line derived xenografts the most common model (82%). 31% of studies focused on normal tissue radiobiology and the lung was the most investigated site. This study captures the trends in preclinical RT research using small animal irradiators from 2007 to 2021. Our data show the increased uptake and outputs from preclinical RT studies in important areas of biology and physics research that could inform translation to clinical trials.

1 February 2019 in Cancers
Verified
Journal Article
Open access
PDF file
MGMihaela Ghita-Pettigrew
Mihaela Ghita-Pettigrew
KBKathryn Brown
Kathryn Brown
OKOlivia J. Kelada
Olivia J. Kelada
Edward Elliot GravesEdward Elliot Graves
Edward Elliot Graves
Karl ButterworthKarl Butterworth
Karl Butterworth
Translational research aims to provide direct support for advancing novel treatment approaches in oncology towards improving patient outcomes. Preclinical studies have a central role in this process and the ability to accurately model biological and physical aspects of the clinical scenario in radiation oncology is critical to translational success. The use of small animal irradiators with disease relevant mouse models and advanced in vivo imaging approaches offers unique possibilities to interrogate the radiotherapy response of tumors and normal tissues with high potential to translate to improvements in clinical outcomes. The present review highlights the current technology and applications of small animal irradiators, and explores how these can be combined with molecular and functional imaging in advanced preclinical radiotherapy research.

1 January 2017 in British Journal of Radiology
Verified
Journal Article
Closed access
Karl ButterworthKarl Butterworth
Karl Butterworth
MGMihaela Ghita-Pettigrew
Mihaela Ghita-Pettigrew
SMStephen J. Mcmahon
Stephen J. Mcmahon
CMConor K Mcgarry
Conor K Mcgarry
RGRobert Griffin
Robert Griffin
KPKevin Prise
Kevin Prise
Objective:Radiotherapy is planned to achieve the optimal physical dose distribution to the target tumour volume whilst minimizing dose to the surrounding normal tissue. Recent in vitro experimental evidence has demonstrated an important role for intercellular communication in radiobiological responses following non-uniform exposures. This study aimed to model the impact of these effects in the context of techniques involving highly modulated radiation fields or spatially fractionated treatments such as spatially fractionated radiotherapy (GRID).Methods:Using the small-animal radiotherapy research platform as a key enabling technology to deliver precision imaged-guided radiotherapy, it is possible to achieve spatially modulated dose distributions that model typical clinical scenarios. In this work, we planned uniform and spatially fractionated dose distributions using multiple isocentres with beam sizes of 0.5–5 mm to obtain 50% volume coverage in a subcutaneous murine tumour model and applied a model of c...